Indonesia-based healthtech firm Halodoc has raised around $80 million in a fresh funding round to expand its services in key healthcare verticals, media reports said. Investors such as Temasek, Bangkok Bank, Novo Holdings and Telkomsel’s venture arm TMI participated in the funding round for Halodoc.
Dr Amit Kakar, Senior Partner, Head of Novo Holdings Asia told the media, “We are very pleased to invest in Halodoc alongside this stellar group of investors. Over the last year, telehealth has been transformational for patients throughout the world. We believe Halodoc is Indonesia’s foremost telehealth platform.”
“We are seeing numerous exciting life sciences and healthcare investment opportunities in the Asia region which have the potential to deliver new treatments, access to healthcare and dramatically improve outcomes for patients. We believe Novo Holdings’ global track record of investing in life sciences and healthcare combined with our long-term approach, partnering mindset and leveraging our global expertise will enable us to build a strong presence in the region.”
Halodoc, which was established in 2016, allows its users in Indonesia to consult with more than 20,000 licensed doctors in the country through its website or mobile application.
Earlier this year, Indonesia again raised its economic recovery budget to $49 billion. The budget for its National Economic Recovery programme, has been raised several times now. In January 2021, the budget was raised to $39 billion. According to the Indonesian finance minister, the budget will help the country fund its vaccination programme.